These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

136 related articles for article (PubMed ID: 16207570)

  • 1. Noninvasive assessment of liver fibrosis.
    Kelleher TB; Afdhal N
    Clin Liver Dis; 2005 Nov; 9(4):667-83, vii. PubMed ID: 16207570
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Noninvasive evaluation of hepatic fibrosis using serum fibrotic markers, transient elastography (FibroScan) and real-time tissue elastography.
    Tatsumi C; Kudo M; Ueshima K; Kitai S; Takahashi S; Inoue T; Minami Y; Chung H; Maekawa K; Fujimoto K; Akiko T; Takeshi M
    Intervirology; 2008; 51 Suppl 1():27-33. PubMed ID: 18544945
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Noninvasive assessment of liver fibrosis: serum markers, imaging, and other modalities.
    Guha IN; Rosenberg WM
    Clin Liver Dis; 2008 Nov; 12(4):883-900, x. PubMed ID: 18984472
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Diagnosis of hepatic fibrosis and cirrhosis].
    Arends JE; de Knegt RJ; van Erpecum KJ; Hoepelman IM
    Ned Tijdschr Geneeskd; 2007 Jul; 151(27):1502-6. PubMed ID: 17763808
    [TBL] [Abstract][Full Text] [Related]  

  • 5.  Noninvasive markers of fibrosis: key concepts for improving accuracy in daily clinical practice.
    Duarte-Rojo A; Altamirano JT; Feld JJ
    Ann Hepatol; 2012; 11(4):426-39. PubMed ID: 22700624
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Measurements of serum procollagen-III peptide and M30 do not improve the diagnostic accuracy of transient elastography for the detection of hepatic fibrosis in patients with nonalcoholic fatty liver disease.
    Ergelen R; Akyuz U; Aydin Y; Eren F; Yilmaz Y
    Eur J Gastroenterol Hepatol; 2015 Jun; 27(6):667-71. PubMed ID: 25923941
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Current complications and challenges in nonalcoholic steatohepatitis screening and diagnosis.
    Golabi P; Sayiner M; Fazel Y; Koenig A; Henry L; Younossi ZM
    Expert Rev Gastroenterol Hepatol; 2016; 10(1):63-71. PubMed ID: 26469309
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Noninvasive assessment of liver fibrosis and portal hypertension with transient elastography.
    Rockey DC
    Gastroenterology; 2008 Jan; 134(1):8-14. PubMed ID: 18166342
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Noninvasive tests for liver disease, fibrosis, and cirrhosis: Is liver biopsy obsolete?
    Carey E; Carey WD
    Cleve Clin J Med; 2010 Aug; 77(8):519-27. PubMed ID: 20682514
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Transient elastography and other noninvasive tests to assess hepatic fibrosis in patients with viral hepatitis.
    Castera L
    J Viral Hepat; 2009 May; 16(5):300-14. PubMed ID: 19254351
    [TBL] [Abstract][Full Text] [Related]  

  • 11. New diagnostic method for liver fibrosis and cirrhosis.
    Han KH; Yoon KT
    Intervirology; 2008; 51 Suppl 1():11-6. PubMed ID: 18544943
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Noninvasive biochemical markers of liver fibrosis.
    Grigorescu M
    J Gastrointestin Liver Dis; 2006 Jun; 15(2):149-59. PubMed ID: 16802010
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Markers of hepatic fibrosis.
    Caballería L; Torán P; Caballería J
    Med Clin (Barc); 2018 Apr; 150(8):310-316. PubMed ID: 29055492
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Non-invasive diagnosis of advanced fibrosis and cirrhosis.
    Sharma S; Khalili K; Nguyen GC
    World J Gastroenterol; 2014 Dec; 20(45):16820-30. PubMed ID: 25492996
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Serum laboratory markers for noninvasive diagnosis and monitoring of liver fibrogenesis in patients with chronic liver diseases.
    Vozar I
    Bratisl Lek Listy; 2005; 106(3):123-6. PubMed ID: 16026147
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Assessment of fibrosis and cirrhosis in liver biopsies: an update.
    Germani G; Hytiroglou P; Fotiadu A; Burroughs AK; Dhillon AP
    Semin Liver Dis; 2011 Feb; 31(1):82-90. PubMed ID: 21344353
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [A clinical study on combined serum hepatic fibrosis-related markers and ultrasound parameters to diagnose hepatic fibrosis].
    Yu J; Jia CH; Wang Q; Xu PS; Zhang H; Zhao YQ; Shen Q; Hao YR; Cai GF
    Zhonghua Shi Yan He Lin Chuang Bing Du Xue Za Zhi; 2007 Mar; 21(1):56-8. PubMed ID: 17429537
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Noninvasive assessment of fibrosis and steatosis in NASH and ASH.
    Angulo P
    Gastroenterol Clin Biol; 2009; 33(10-11):940-8. PubMed ID: 19800187
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Clinical application of non-invasive diagnosis for hepatic fibrosis].
    Cho SW; Cheong JY
    Korean J Hepatol; 2007 Jun; 13(2):129-37. PubMed ID: 17585186
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Transient elastography for diagnosis of advanced fibrosis and portal hypertension in patients with hepatitis C recurrence after liver transplantation.
    Carrión JA; Navasa M; Bosch J; Bruguera M; Gilabert R; Forns X
    Liver Transpl; 2006 Dec; 12(12):1791-8. PubMed ID: 16823833
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.